Mpox News and Research

Latest Mpox News and Research

Enveloped viruses show greater cross-species transmission, according to new research

New research found that enveloped viruses harbor greater cross-species transmissibility and are more likely to cause zoonotic infections than nonenveloped viruses.

9 Dec 2022

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers from the University of Maine and University of Massachusetts Amherst have designed new liquid-coated air filters that allow for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.

7 Dec 2022

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Researchers evaluated the immunogenicity, boosting efficacy, and safety of single-dose and two-dose MVA-BN (modified vaccinia Ankara-Bavarian Nordic) vaccinations in comparison to replicating smallpox vaccines.

7 Dec 2022

Characterizing mpox cases among women in Spain

Researchers characterized mpox (formerly Monkeypox) cases among women in Spain between April and November 2022.

6 Dec 2022

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

A phase III clinical trial showed consistent immunogenicity for a freeze-dried formulation of Bavarian Nordic's Modified Vaccinia Ankara.

5 Dec 2022

Mpox virus from Clade 2b is the least virulent strain according to new study

Researchers used the CAST/EiJ mouse model to test whether genetic differences between clades 1, 2a, and 2b of the monkeypox virus contribute to changes in transmission and virulence of the disease.

5 Dec 2022

Much of the CDC is working remotely. That could make changing the agency difficult.

Earlier this year, top leadership at the Centers for Disease Control and Prevention began a monumental task: turning the sprawling, labyrinthine organization known for its highly specialized, academically focused scientific research into a sleek, flexible public health response agency primed to serve the American public.

5 Dec 2022

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers developed an mRNA technology-based vaccine candidate against the monkeypox virus and evaluated its immunogenicity in animal models.

5 Dec 2022

Study on mpox epidemiology in New York during summer 2022

Researchers presented a summary of their experience of identifying, managing, and vaccinating monkeypox (MPX) virus (MPXV)-infected individuals in New York during the summer season of 2022.

30 Nov 2022

New evidence of mpox virus transmission before onset of symptoms

Researchers extensively followed-up high-risk contacts of clade IIb mpox (MPX) virus (MPXV)-infected patients to evaluate the risk of MPX after MPXV exposure and to characterize early MPXV infections.

30 Nov 2022

A new use for dating apps: Chasing STIs

Heather Meador and Anna Herber-Downey use dating apps on the job — and their boss knows it.

30 Nov 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Researchers estimated the single-dose MVA-BN vaccine effectiveness against symptomatic mpox among high-risk gay, bisexual and other men who have sex with men in England.

29 Nov 2022

Study on the immunogenicity of monkeypox virus messenger ribonucleic acid-based vaccine candidates

In a new study, researchers developed two monkeypox (MPX) virus (MPXV) quadrivalent messenger ribonucleic acid (mRNA) vaccines, mRNA-A-lipid nanoparticle (LNP) and mRNA-B-LNP.

28 Nov 2022

Modeling study offers a road map for public health to maximize the impact of monkeypox vaccines

A modeling study to explore optimal allocation of vaccines against monkeypox virus (MPXV) provides a road map for public health to maximize the impact of a limited supply of vaccines.

28 Nov 2022

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Researchers determined whether neutralizing antibody levels were predictive of the efficacy of fractional vaccine doses against SARS-CoV-2 infection.

24 Nov 2022

Study shows no undetected monkeypox virus transmission before May 2022 in Rotterdam and Amsterdam

Researchers investigated whether undetected human monkeypox virus transmission occurred before Rotterdam and Amsterdam's first documented monkeypox cases.

23 Nov 2022

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.

22 Nov 2022

Monkeypox viruses can be inactivated by two who-recommended hand disinfectants

People in many countries are contracting monkeypox, even though they have not travelled to any regions where the virus is mainly circulating.

22 Nov 2022

Epidemiological and clinical characteristics of monkeypox virus infection in cis and trans women and non-binary individuals

A recent study described the clinical and epidemiologic features of infection with monkeypox virus (MPXV) in cisgender (cis) and transgender (trans) females and non-binary individuals.

22 Nov 2022

Mpox News and Research

Latest Mpox News and Research

Enveloped viruses show greater cross-species transmission, according to new research

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Characterizing mpox cases among women in Spain

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

Mpox virus from Clade 2b is the least virulent strain according to new study

Much of the CDC is working remotely. That could make changing the agency difficult.

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Study on mpox epidemiology in New York during summer 2022

New evidence of mpox virus transmission before onset of symptoms

A new use for dating apps: Chasing STIs

Monkeypox renamed "mpox" in an effort to combat stigma

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Study on the immunogenicity of monkeypox virus messenger ribonucleic acid-based vaccine candidates

Modeling study offers a road map for public health to maximize the impact of monkeypox vaccines

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Study shows no undetected monkeypox virus transmission before May 2022 in Rotterdam and Amsterdam

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Monkeypox viruses can be inactivated by two who-recommended hand disinfectants

Epidemiological and clinical characteristics of monkeypox virus infection in cis and trans women and non-binary individuals

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Neuroscience eBook

Mpox News and Research

Latest Mpox News and Research

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Neuroscience eBook

Newsletters you may be interested in